𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impulse control disorders in Chinese Parkinson’s disease patients: The effect of ergot derived dopamine agonist

✍ Scribed by M. Auyeung; T.H. Tsoi; W.K. Tang; C.M. Cheung; C.N. Lee; R. Li; Eric Yeung

Book ID
116821009
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
114 KB
Volume
17
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiparkinsonian activity of a non-ergot
Antiparkinsonian activity of a non-ergot dopamine agonist, CV 205-502, in patients with fluctuating Parkinson's disease
✍ Dr. W. Poewe; G. Luef; B. Kleedorfer; M. Emre 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

## Abstract Six patients with fluctuating Parkinson's disease received single rising oral doses of the nonergot dopamine agonist CV 205‐502 in an open experimental study. Doses of 0.5 mg produced antiparkinsonian effects of comparable intensity but longer duration than 200 mg of L‐DOPA. CV 205‐502,